CrpaA.01238.a
Seryl-tRNA synthetase, cytoplasmic (SerRS)
CENTER ID:
CrpaA.01238.a
ORGANISM:
Cryptosporidium parvum Iowa II
ASSOCIATED DISEASE:
cryptosporidiosis - (diarrheal disease)
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
IIIB
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
CrpaA.01238.a.AE1.GE42988
full length
info
1
454
CrpaA.01238.a.AE1.GE42988
CrpaA.01238.a.B1.GE41424
full length
info
1
454
CrpaA.01238.a.B1.GE41424
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
CrpaA.01238.a.HW1.PW38389
full length
info
1
454
PW38389
CrpaA.01238.a.AE1.PW38630
full length
info
1
454
PW38630
Structures
6OTE
DEPOSITED: 5/3/2019
DETERMINATION: XRay
CLONE: CrpaA.01238.a.HZ1.GE41770
PROTEIN: CrpaA.01238.a.HZ1.PW38382
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MPIDINRIRV EKGGDYQKIA ESEMARYKGL ETLEELVKVD QKWREDMFKL EQSKKELNSI SKEIAQIKKK DPKADCKDLQ DKSVQLKKNL PIIEKQALET EEVRDKLWHK IGNVLQPDVP ISNTEDDNLV LRTWGEIPDI KVDGTPGKLH HNEIMSRLGF YDSVKGAELA GHRGYFLKDY GVIMSMALSH YAMGFLLKKG YLAIQPPYFM KRDLMGKAAE LQDFEETLYH IPSDNSKGEV DSNSLFLIAT SEQPIAAMHH NVTLEDKDLP IKYAGISTCF RKEAGAHGKD TWGIFRIHQF EKVEQFCVTL PEDSQKIHEE MISISEEFYQ SLELPYRVIS IVSGALNDAA SKKYDLEAWF PGYNSYRELV SCSNCTDYQS RALECRLGFR KEGEREKHYC HFLNGTLCAI QRTMCCIVEN YQTPDGLRIP KVLQPYMNGV EFIPFKNETA TCAN
NT Sequence
atgcctatag atattaatag aattagagtg gagaaaggtg gagattatca aaagatagcc gagtcagaaa tggcaaggta taaaggacta gaaactcttg aggaactcgt taaagtagat cagaaatgga gagaggatat gtttaaatta gagcaaagca aaaaggagtt aaattcaatt tcaaaagaaa ttgctcaaat taaaaagaaa gatccaaagg cagattgcaa ggatttacaa gacaaaagcg ttcaattaaa gaagaatctt ccaattatcg agaaacaagc attggaaact gaagaagtaa gagataagtt atggcataaa attggtaatg tcttacaacc tgatgttcct atttccaata cagaggatga caaccttgta ttgagaacat ggggagaaat accagatatt aaggttgatg gaacaccagg gaaattgcat cacaatgaaa tcatgtccag attaggattc tatgatagtg tgaaaggtgc agaattagca ggccatcgtg gttacttttt aaaggattat ggtgtaataa tgagtatggc tctctcacat tatgctatgg gattcttgtt aaaaaaagga tatttggcaa ttcaaccgcc atactttatg aaaagagatt tgatgggtaa agcagctgaa ttgcaggact ttgaggagac actttatcac attccttctg ataacagcaa aggcgaggtt gattcaaata gcttattttt gattgcaaca tctgagcaac caatagctgc aatgcatcat aatgtgacac ttgaagataa ggacttacca atcaaatatg ctggtatttc aacatgcttt agaaaagagg caggcgctca tggtaaagat acctggggaa tatttagaat tcatcaattt gaaaaagttg agcaattctg tgttacttta ccagaagact cacaaaagat tcatgaggaa atgattagca tttccgagga attttatcaa tctttggaat taccttatag agtaatttca atcgtatcag gagcgcttaa tgacgctgca tcgaaaaagt atgatttaga agcttggttc cccggatata actcatatag ggaacttgtt tcatgctcaa actgtactga ttaccaatct agagcgcttg aatgtcgtct gggattcaga aaagaaggag agcgtgaaaa acattactgc catttcctaa acggtacttt atgtgcaatc caaagaacaa tgtgctgtat tgttgaaaac tatcaaactc cagatggtct tagaatacca aaagtcttac agccttatat gaatggcgtc gaattcattc cattcaaaaa cgaaaccgct acttgtgcca attag
Details for CrpaA.01238.a.AE1.GE42988
HARVESTED ON:
3/4/2019
SEQUENCED ON:
3/12/2019
EXPECTED MW:
53kDa
OBSERVED MW:
53kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for CrpaA.01238.a.B1.GE41424
HARVESTED ON:
4/5/2017
SEQUENCED ON:
4/27/2017
EXPECTED MW:
53kDa
OBSERVED MW:
55kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Low Expression
SOLUBLE EXPRESSION LEVEL
Low Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
99
PERCENT COVERAGE:
98
Details for CrpaA.01238.a.HW1.PW38389
PURIFICATION DATe:
11/13/2017
CONCENTRATION:
27.87mg/ml
OBSERVED MW:
67kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
2
VIAL VOLUME:
200µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable
Details for CrpaA.01238.a.AE1.PW38630
PURIFICATION DATe:
6/4/2019
CONCENTRATION:
75mg/ml
OBSERVED MW:
52kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
10
VIAL VOLUME:
27µl
PERCENT IDENTITY:
data unavailable
PERCENT COVERAGE:
data unavailable